Diuretic and natriuretic effect of a brain soluble fraction that inhibits neuronal Na+,K(+)-ATPase.
The separation by Sephadex G-50 of two subfractions, peak I and II, from the brain soluble fraction has been previously described. These fractions were able to stimulate and inhibit synaptosomal membrane Na+,K(+)-ATPase, respectively (Rodríguez de Lores Arnaiz and Antonelli de Gómez de Lima, Neurochem. Res. 11, 933-948, 1986). Experimental evidence indicates that the alteration of Na+,K(+)-ATPase activity may result in changes of renal and cardiovascular parameters. In the present study, we have analyzed the effect of peak I and II fractions prepared from rat cerebral cortex on water and sodium excretion and on heart rate and arterial pressure in normotensive anesthetized rats. It was observed that water and sodium excretion were not modified by the administration of peak I fraction but that they were increased by peak II fraction. The cardiovascular parameters were not significantly modified by either of the fractions. The results indicate that brain soluble factor (s) which is (are) present in peak II fraction may modify some aspects of renal physiology after systemic administration.
Nowicki
S
S
Cátedra de Farmacología, Facultad de Farmacia y Bioquímica, UBA, Argentina.
Enero
M A
MA
Rodriguez de Lores Arnaiz
G
G
D000818:Animals; D001685:Biological Factors / Q000008:administration & dosage / Q000494:pharmacology*; D001794:Blood Pressure; D002540:Cerebral Cortex / Q000737:chemistry*; D002850:Chromatography, Gel; D004231:Diuresis; D005260:Female; D006339:Heart Rate; D008297:Male; D009318:Natriuresis; D009474:Neurons / Q000201:enzymology; D051381:Rats; D011919:Rats, Inbred Strains; D000254:Sodium-Potassium-Exchanging ATPase / Q000037:antagonists & inhibitors*
D001685:Biological Factors; D000254:Sodium-Potassium-Exchanging ATPase